T Mohanakumar
Overview
Explore the profile of T Mohanakumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
361
Citations
3232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bansal S, Itabashi Y, Guerrero-Alba A, Fleming T, Smith M, Bremner R, et al.
Transpl Immunol
. 2024 Sep;
87:102113.
PMID: 39222773
Introduction: A better understanding of the immune mechanisms involved in allograft rejection after transplantation is urgently needed to improve patient outcomes. As microRNA-155 (miR155) plays a critical role in inflammation,...
2.
Guerrero-Alba A, Bansal S, Sankpal A, Mitra G, Rahman M, Ravichandran R, et al.
Front Mol Biosci
. 2024 Aug;
11:1365783.
PMID: 39211743
In the realm of biomedical advancement, extracellular vesicles (EVs) are revolutionizing our capacity to diagnose, monitor, and predict disease progression. However, the comprehensive exploration and clinical application of EVs face...
3.
Bansal S, Arjuna A, Franz B, Guerrero-Alba A, Canez J, Fleming T, et al.
Front Transplant
. 2024 Jul;
2:1248987.
PMID: 38993876
Identification of recipients with pre-existing antibodies and cross-matching of recipient sera with donor lymphocytes have reduced the incidence of antibody-mediated rejection (AMR) after human lung transplantation. However, AMR is still...
4.
Bansal S, Fleming T, Canez J, Maine G, Bharat A, Walia R, et al.
Transpl Immunol
. 2023 Oct;
81:101940.
PMID: 37866672
Humoral and cellular immune responses to SARS-CoV-2 and other coronaviruses in lung transplant recipients are unknown. We measured antibodies and T cell responses against the SARS-CoV-2 spike S2 and nucleocapsid...
5.
Rahman M, Ravichandran R, Sankpal N, Bansal S, Sureshbabu A, Fleming T, et al.
Cell Immunol
. 2023 Feb;
386:104690.
PMID: 36812767
Background: We recently demonstrated decreased tumor suppressor gene liver kinase B1 (LKB1) level in lung transplant recipients diagnosed with bronchiolitis obliterans syndrome. STE20-related adaptor alpha (STRADα) functions as a pseudokinase...
6.
Me H, Ravichandran R, Khamash H, Nair S, Hacke K, Ramon D, et al.
Transplant Proc
. 2022 Nov;
54(10):2765-2768.
PMID: 36376103
There is a lower incidence of antibody-mediated rejection (AMR) after simultaneous liver-kidney transplantation (SLKT) than after kidney-only transplantation. It has been suggested that soluble human leukocyte antigen (sHLA) produced by...
7.
Itabashi Y, Ravichandran R, Bansal S, Chin C, Poulson C, Sureshbabu A, et al.
Transpl Immunol
. 2022 Aug;
75:101702.
PMID: 36038048
Objective: Antibodies against donor human leukocyte antigen are a risk factor for chronic immune injury (CII) following renal transplantation; however, it is often not detectable. The main goal of this...
8.
Bansal S, Tokman S, Fleming T, Maine G, Sanborn K, Hachem R, et al.
Clin Transl Med
. 2021 Nov;
11(11):e576.
PMID: 34841719
No abstract available.
9.
Bansal S, Limaye A, Lee J, Fleming T, Poulson C, Omar A, et al.
Transpl Immunol
. 2021 Oct;
69:101480.
PMID: 34619318
Background: Chronic lung transplant rejection occurs in over 50% of lung transplant recipients and mechanism of chronic rejection is unknown. Evaluation of potential mechanism of exosomes from lung transplant recipients...
10.
Lee J, Chen R, Mohanakumar T, Bremner R, Mittal S, Fleming T
Onco Targets Ther
. 2021 Jun;
14:3813-3820.
PMID: 34188489
Introduction: Esophageal cancer (EC) is an aggressive cancer type that is increasing at a high rate in the US and worldwide. Extensive sequencing of EC specimens has shown that there...